NO20005763L - DHEA-sammensetning og fremgangsmåte - Google Patents

DHEA-sammensetning og fremgangsmåte

Info

Publication number
NO20005763L
NO20005763L NO20005763A NO20005763A NO20005763L NO 20005763 L NO20005763 L NO 20005763L NO 20005763 A NO20005763 A NO 20005763A NO 20005763 A NO20005763 A NO 20005763A NO 20005763 L NO20005763 L NO 20005763L
Authority
NO
Norway
Prior art keywords
dhea
composition
dhea composition
Prior art date
Application number
NO20005763A
Other languages
English (en)
Other versions
NO20005763D0 (no
NO327981B1 (no
Inventor
Jagdish Parasrampuria
Maxine B Yonker
Kenneth E Schwartz
Marc J Gurwith
Original Assignee
Genelabs Tech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Tech Inc filed Critical Genelabs Tech Inc
Publication of NO20005763D0 publication Critical patent/NO20005763D0/no
Publication of NO20005763L publication Critical patent/NO20005763L/no
Publication of NO327981B1 publication Critical patent/NO327981B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NO20005763A 1999-03-18 2000-11-14 Farmasoytisk preparat inneholdende dehydroepiandrosteron, fremgangsmate for dets fremstilling samt anvendelser derav. NO327981B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12520199P 1999-03-18 1999-03-18
PCT/US2000/006987 WO2000054763A2 (en) 1999-03-18 2000-03-16 Pharmaceutical compositions comprising polymorphic forms of dehydroepiandrosterone

Publications (3)

Publication Number Publication Date
NO20005763D0 NO20005763D0 (no) 2000-11-14
NO20005763L true NO20005763L (no) 2001-01-10
NO327981B1 NO327981B1 (no) 2009-11-02

Family

ID=22418636

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005763A NO327981B1 (no) 1999-03-18 2000-11-14 Farmasoytisk preparat inneholdende dehydroepiandrosteron, fremgangsmate for dets fremstilling samt anvendelser derav.

Country Status (14)

Country Link
EP (2) EP2233141A1 (no)
JP (1) JP2002539158A (no)
KR (1) KR20010043716A (no)
CN (2) CN101543500A (no)
AU (1) AU779138B2 (no)
BR (1) BR0005392A (no)
CA (1) CA2332767A1 (no)
IL (1) IL139386A (no)
MX (1) MXPA00011329A (no)
NO (1) NO327981B1 (no)
NZ (1) NZ507880A (no)
RU (1) RU2220727C2 (no)
WO (1) WO2000054763A2 (no)
ZA (1) ZA200006340B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605591B1 (en) * 1999-11-12 2003-08-12 Genelabs Technologies, Inc. Treatment of subnormal bone mineral density
US6552010B1 (en) 1999-11-12 2003-04-22 Genelabs Technologies, Inc. Treatment of SLE with dehydroepiandrosterone
AU2002303427A1 (en) 2001-04-24 2002-11-05 East Carolina University Compositions and formulations with a non-glucocorticoid steroid and/or a ubiquinone and kit for treatment of respiratory and lung disease
EP1553954A4 (en) * 2002-06-17 2009-12-23 Epigenesis Pharmaceuticals Llc DIHYDRATE DEHYDROEPIANDROSTERONE AND METHOD FOR THE TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE LUNG DISEASE, COMPOSITIONS THEREOF
US7405207B2 (en) 2002-06-17 2008-07-29 Epigenesis Pharmaceuticals, Inc. Nebulizer formulations of dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
KR102033187B1 (ko) * 2011-07-19 2019-10-16 판타레이 바이오사이언스 비.브이. 디하이드로에피안드로스테론(ｄｈｅａ)을 함유하는 정제
EP2986634B1 (en) * 2013-04-19 2019-11-20 University of Houston System Cocrystalline dhea formulations
RU2545812C1 (ru) * 2014-02-24 2015-04-10 Аллан Герович Бениашвили Ородисперсная таблетка дегидроэпиандростерона
RU2557960C1 (ru) * 2014-07-01 2015-07-27 Аллан Герович Бениашвили Ородисперсная таблетка дегидроэпиандростерона и/или комбинации дегидроэпиандростерона и l-тианина
CN113406254B (zh) * 2021-07-21 2023-03-07 裕菁科技(上海)有限公司 一种同时检测多种外源性和内源性甾体激素的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4518595A (en) 1983-07-19 1985-05-21 The Jackson Laboratory Method for treating diabetes using DHEA compounds
US5077284A (en) 1988-12-30 1991-12-31 Loria Roger M Use of dehydroepiandrosterone to improve immune response
IE63051B1 (en) * 1989-03-18 1995-03-22 Akzo Nv Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha, 17alpha)-17-Hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn- 3-one
ZA924811B (en) 1991-06-28 1993-12-29 Endorecherche Inc Controlled release systems and low dose androgens
WO1994008589A1 (en) 1992-10-09 1994-04-28 The Board Of Trustees Of The Leland Stanford Junior University Treatment of systemic lupus erythematosus with dehydroepiandrosterone
US5776923A (en) 1993-01-19 1998-07-07 Endorecherche, Inc. Method of treating or preventing osteoporosis by adminstering dehydropiandrosterone
PT1382340E (pt) * 1993-01-19 2006-07-31 Endorech Inc Utilizacoes terapeuticas de desidroepiandrosterona para tratar libido diminuida e osteoporose
JP3862295B2 (ja) 1993-09-30 2006-12-27 独立行政法人理化学研究所 抗肥満剤
US5855548A (en) 1996-06-14 1999-01-05 Vivus, Incorporated Venous flow control element for maintaining penile erection
US5861391A (en) 1997-01-29 1999-01-19 Research Development Foundation Use of dehydroepiandrosterone to treat primary adrenal insufficiency and Addison's disease
US5935949A (en) 1998-03-20 1999-08-10 Trustees Of Dartmouth College Use of androgen therapy in fibromyalgia and chronic fatigue syndrome
RU2165267C1 (ru) * 1999-12-15 2001-04-20 Воронежский государственный аграрный университет им. К.Д. Глинки Способ борьбы с аспергиллезом при дезинфекции животноводческих помещений

Also Published As

Publication number Publication date
MXPA00011329A (es) 2002-04-17
KR20010043716A (ko) 2001-05-25
ZA200006340B (en) 2001-05-23
JP2002539158A (ja) 2002-11-19
NO20005763D0 (no) 2000-11-14
AU3753900A (en) 2000-10-04
CN100544726C (zh) 2009-09-30
CN101543500A (zh) 2009-09-30
NO327981B1 (no) 2009-11-02
EP1778246A2 (en) 2007-05-02
AU779138B2 (en) 2005-01-06
CA2332767A1 (en) 2000-09-21
RU2220727C2 (ru) 2004-01-10
NZ507880A (en) 2003-12-19
IL139386A (en) 2006-08-01
CN1407897A (zh) 2003-04-02
WO2000054763A2 (en) 2000-09-21
IL139386A0 (en) 2001-11-25
WO2000054763A3 (en) 2001-09-07
BR0005392A (pt) 2001-01-30
EP2233141A1 (en) 2010-09-29

Similar Documents

Publication Publication Date Title
NO20022334L (no) Ny sammensetning og anvendelse
DK1339292T3 (da) Sammensætning og fremgangsmåde
NO20013393L (no) Bronnsementeringsfremgangsmater og sammensetninger
NO20000011D0 (no) Skumdempersammensetninger og fremgangsmåter
NO20022086L (no) Antidiabetisk formulering og fremgangsmåte
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1454907T3 (da) Quninazolin og pyridopyrmidin-derivativer
NO20005828L (no) Herdbare punktfluidsammensetninger og fremgangsmåter
NO20000847L (no) Elastiske brønnsementsammensetninger og fremgangsmÕter
DE60044764D1 (de) Durchgangs -Vorrichtung und -Verfahren
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
NO20006488D0 (no) Sammensetning og anvendelse
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
FI20011887L (fi) Kantapäälaite ja -menetelmä
AU6832101A (en) Composition and method
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20001485L (no) Redigeringsanordning og redigeringsfremgangsmÕte
DE60019627D1 (de) Ferrofluid-zusammensetzung und verfahren
AU4163402A (en) Composition and method
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
IS2841B (is) Samstæða hluta og lyfjasamsetningar
DE69916503D1 (de) Poliermittelzusammensetzung und anwendungsverfahren
DE60028486D1 (de) Videocoder und -decoder
NO20005763D0 (no) DHEA-sammensetning og metode
FI19992112L (fi) Synkronointimenetelmä ja -järjestely

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees